PSMA Therapy and Immunotherapy in Kidney Cancer
Conditions: Metastatic Renal Cell Carcinoma; Metastatic Clear Cell Renal Cell Carcinoma Interventions: Drug: Pembrolizumab; Drug: 177Lu-PNT2002; Drug: (F-18)-DCFPyL Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Merck Sharp& Dohme LLC; Lantheus Medical Imaging Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Kidney Cancer | Merck | Renal Cell Carcinoma | Research | Urology & Nephrology